Loading...
01/11 11:29
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Despite some positive indicators like increased operating cash flows and improved renewal rates, the overall sentiment is negative due to declining revenue guidance, subscription revenue decline, and management's vague responses on critical renewal issues. The Q&A highlighted budget constraints, particularly in life sciences, and expected gross margin pressure. These factors suggest a challenging environment, likely leading to a negative stock price reaction.
Total Revenue $60 million, down 4% year-over-year. This was driven by another quarter of modest year-over-year improvement in renewal rates.
Adjusted EBITDA $18.9 million, representing a margin of 32%, which was $2 million above the high end of guidance. This reflects continued operational improvements with a focus on maintaining solid expense discipline.
Unlevered Free Cash Flow Approximately $51 million for the trailing 12 months, reflecting strong cash flow generation.
Subscription Revenues $58.2 million, declined 4% year-over-year, reflecting stabilization in absolute dollars quarter-over-quarter and a 2-point trajectory improvement over the subscription growth rate in the prior quarter.
Adjusted Gross Profit $49.4 million, down 4% from Q3 2024, reflecting the revenue decline. Adjusted gross profit margin of 82% was roughly flat from Q3 2024.
Operating Cash Flows $59.2 million on a trailing 12-month basis, up 8% from the comparable period a year ago, benefiting from strong collections and higher deferred revenue.
Deferred Revenue $92 million, up 7% year-over-year, reflecting growth in remaining performance obligations.
New claims data source: Introduced in Q3 to address data disruption in the market segment.
Syndicated go-to-market partnership with LiveRamp: Launched to support customers' ad tech efforts, enabling marketers to self-serve using prebuilt audience segments.
Enterprise customer growth: Enterprise customer count increased by 10 to 520, the highest since Q3 last year.
Agency partnerships: Signed 8 new agencies in Q3 to expand digital engagement.
Revenue: $60 million in Q3, down 4% year-over-year, but at the high end of guidance.
Adjusted EBITDA: $18.9 million, representing a 32% margin, $2 million above guidance.
Retention rates: Improved year-over-year, though durability of the trend is uncertain.
Cost savings: Achieved $2.5 million in Q3 through data contract renegotiation and replacing a disrupted data source.
Differentiated data: Expanded data sets with new sources, including a new claims data source, and plans to add another source to exceed historical data levels.
Seamless integrations: Focused on embedding data into customer workflows, leading to higher retention rates.
Customer success: Enhanced customer engagement processes to improve retention and value delivery.
Digital partnerships and innovation: Progress in ad tech efforts and partnerships, including a significant new strategic partner and expanded agency presence.
Revenue Decline: Total revenue was $60 million, down 4% year-over-year, indicating challenges in maintaining or growing revenue.
Renewal Rates: While there was modest year-over-year improvement in renewal rates, it remains too early to call this trend durable, and the company faces a large renewal cohort in December and January, posing risks to retention.
Data Disruption: The company faced disruptions in the claims data market over the past year, requiring investments in new data sources to address these challenges.
Macroeconomic Environment: The company operates in a dynamic macroeconomic environment, which could impact customer spending and renewal rates.
Retention Rates: Retention rates have shown improvement but are not yet at levels that would enable consistent top-line growth, indicating ongoing challenges in customer retention.
Integration Challenges: Efforts to integrate data into customer systems are critical for retention, but achieving seamless integration remains a challenge.
Competitive Pressures: The company faces competition in providing differentiated data and seamless integrations, which are critical to winning and retaining customers.
Strategic Partnerships: While new partnerships are being developed, they take time to generate revenue, posing a delay in realizing financial benefits.
Customer Success: The company is revisiting its customer engagement process to improve retention and value delivery, indicating current gaps in customer success strategies.
Innovation and Digital Engagement: Investments in innovation and digital engagement are ongoing, but the time required to see returns on these investments could delay financial improvements.
Revenue Expectations: For Q4 2025, the company expects to deliver $59 million to $60 million in revenue, representing a decrease of 4% to 5% compared to Q4 2024. For the full year 2025, revenue is expected to be $239 million to $240 million, a 5% decline year-over-year.
Profitability Projections: For Q4 2025, adjusted operating income is expected to be $13.5 million to $14.5 million, adjusted EBITDA is projected at $16 million to $17 million (27% to 29% margin), and adjusted net income is forecasted at $8 million to $9 million ($0.05 to $0.06 per diluted share). For the full year 2025, adjusted EBITDA is expected to be $68 million to $69 million (28% to 29% margin), and adjusted net income is projected at $34 million to $35 million ($0.23 to $0.24 per diluted share).
Customer Retention and Growth: The company is cautiously optimistic about improving retention rates but remains cautious about macroeconomic pressures. Efforts to improve customer retention and expand enterprise customer count are ongoing.
Strategic Investments: Planned investments include enhancing data assets, expanding claims data sources, and supporting digital engagement strategies. These investments aim to improve customer retention and drive long-term growth.
Market Trends and Conditions: The company remains cautious about the macroeconomic environment and its impact on renewals and growth. However, it is focused on leveraging its differentiated data and operational strategies to navigate these challenges.
Share Repurchase: Repurchased approximately 2 million shares in the quarter for a total of about $9 million with about $49 million remaining under our authorization.
Despite some positive indicators like increased operating cash flows and improved renewal rates, the overall sentiment is negative due to declining revenue guidance, subscription revenue decline, and management's vague responses on critical renewal issues. The Q&A highlighted budget constraints, particularly in life sciences, and expected gross margin pressure. These factors suggest a challenging environment, likely leading to a negative stock price reaction.
The earnings call presents a mixed picture: strong Q2 renewals and operational improvements are positives, but cautious guidance and challenges in life sciences weigh negatively. The company's focus on customer success and integration capabilities is promising, yet macroeconomic uncertainties and a decline in subscription revenues temper optimism. The Q&A section reveals cautious sentiment from analysts, especially regarding renewal timing and upsell pressures. Without significant catalysts like new partnerships or guidance changes, the stock is likely to remain stable in the near term.
The earnings call reveals several negative indicators: revenue and EBITDA declines, decreased customer count, goodwill impairment, and unfavorable churn dynamics. Despite some positive aspects, like strong cash flow and a share buyback program, the negative guidance for 2025 and concerns over pricing pressure and leadership transitions contribute to a negative sentiment. The Q&A section highlights challenges with churn and pricing pressure. The stock is likely to react negatively, within the -2% to -8% range, considering the overall negative financial outlook and market uncertainties.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
